Trader Biora Therapeutics Inc. - BIOR CFD
Ajouter aux favoris- Résumé
- Données historiques
- Événements
- Compte de résultat
- Bilan
- Flux de trésorerie
- Capital
Écart | 0.0316 | ||||||||
Frais de position longue en overnight
Long position overnight fee
Aller vers la plateforme | -0.025457% | ||||||||
Frais de position courte en overnight
Short position overnight fee
Aller vers la plateforme | 0.003235% | ||||||||
Durée des frais en overnight | 21:00 (UTC) | ||||||||
Quantité minimale négociée | 0.01 | ||||||||
Devise | USD | ||||||||
Marge | 20% | ||||||||
Bourse | United States of America | ||||||||
Commission sur la négociation | 0% |
*Information provided by Capital.com
Biora Therapeutics Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Fermeture précédente* | 4.3994 |
Ouvert* | 4.2895 |
Variation sur 1 an* | 449.94% |
Fourchette du jour* | 4.2895 - 4.6687 |
Fourchette sur 52 semaines | 1.95-28.75 |
Volume moyen (10 jours) | 365.20K |
Volume moyen (3 mois) | 3.12M |
Capitalisation boursière | 52.42M |
Ratio C/B | -100.00K |
Actions en circulation | 11.86M |
Revenu | 200.00K |
EPS | -6.00 |
Dividende (rendement en %) | N/A |
Bêta | -100.00K |
Prochaine date de publication des résultats | Aug 14, 2023 |
Toutes les données sont fournies par Refinitiv, à l'exception des données marquées d'un astérisque, qui sont des *données fournies par Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Clôture | Change | Change (%) | Ouverture | High | Low |
---|---|---|---|---|---|---|
Jun 2, 2023 | 4.4792 | 0.1098 | 2.51% | 4.3694 | 4.6887 | 4.2895 |
Jun 1, 2023 | 4.3994 | -0.0399 | -0.90% | 4.4393 | 4.4393 | 4.2397 |
May 31, 2023 | 4.4393 | 0.0699 | 1.60% | 4.3694 | 4.5391 | 4.3095 |
May 30, 2023 | 4.5391 | 0.2895 | 6.81% | 4.2496 | 4.6289 | 4.1398 |
May 26, 2023 | 4.2398 | -0.2493 | -5.55% | 4.4891 | 4.5590 | 3.8905 |
May 25, 2023 | 4.4593 | -0.4289 | -8.77% | 4.8882 | 5.0577 | 4.2995 |
May 24, 2023 | 4.6887 | 0.6984 | 17.50% | 3.9903 | 4.8184 | 3.9802 |
May 23, 2023 | 3.9704 | -0.8679 | -17.94% | 4.8383 | 4.8982 | 3.8706 |
May 22, 2023 | 4.8384 | 1.1274 | 30.38% | 3.7110 | 5.0778 | 3.6411 |
May 19, 2023 | 3.6711 | 0.1895 | 5.44% | 3.4816 | 3.7210 | 3.3119 |
May 18, 2023 | 3.3120 | 0.0699 | 2.16% | 3.2421 | 3.3818 | 3.2221 |
May 17, 2023 | 3.3020 | 0.0001 | 0.00% | 3.3019 | 3.4018 | 3.0924 |
May 16, 2023 | 3.4517 | 0.2395 | 7.46% | 3.2122 | 3.6412 | 3.0525 |
May 15, 2023 | 3.3320 | -0.2592 | -7.22% | 3.5912 | 3.6711 | 3.2920 |
May 12, 2023 | 3.6311 | 0.2394 | 7.06% | 3.3917 | 3.6312 | 3.1921 |
May 11, 2023 | 3.2521 | 0.3493 | 12.03% | 2.9028 | 3.3918 | 2.8929 |
May 10, 2023 | 2.9329 | 0.1398 | 5.01% | 2.7931 | 3.0227 | 2.7532 |
May 9, 2023 | 2.8331 | 0.1796 | 6.77% | 2.6535 | 2.9628 | 2.6535 |
May 8, 2023 | 2.6535 | 0.1597 | 6.40% | 2.4938 | 2.7134 | 2.4938 |
May 5, 2023 | 2.5438 | 0.0499 | 2.00% | 2.4939 | 2.5837 | 2.4140 |
Biora Therapeutics Inc. Events
Heure (UTC) (UTC) | Pays | Événement |
---|---|---|
Wednesday, June 14, 2023 | ||
Heure (UTC) (UTC) 17:00 | Pays US
| Événement Biora Therapeutics Inc Annual Shareholders Meeting Biora Therapeutics Inc Annual Shareholders MeetingForecast -Previous - |
Thursday, June 15, 2023 | ||
Heure (UTC) (UTC) 18:00 | Pays US
| Événement Biora Therapeutics Inc Annual Shareholders Meeting Biora Therapeutics Inc Annual Shareholders MeetingForecast -Previous - |
Monday, August 14, 2023 | ||
Heure (UTC) (UTC) 10:59 | Pays US
| Événement Q2 2023 Biora Therapeutics Inc Earnings Release Q2 2023 Biora Therapeutics Inc Earnings ReleaseForecast -Previous - |
Monday, November 13, 2023 | ||
Heure (UTC) (UTC) 10:59 | Pays US
| Événement Q3 2023 Biora Therapeutics Inc Earnings Release Q3 2023 Biora Therapeutics Inc Earnings ReleaseForecast -Previous - |
- Annuel
- Trimestriel
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Revenu total | 0.305 | 1.247 | 0.162 | 143.985 | 127.974 |
Revenu | 0.305 | 1.247 | 0.162 | 143.985 | 127.974 |
Coût des recettes, total | 0 | 0 | 100.492 | 92.076 | |
Résultat brut | 1.247 | 0.162 | 43.493 | 35.898 | |
Total des frais d'exploitation | 63.686 | 119.984 | 118.981 | 284.104 | 242.213 |
Total des frais de vente/Généraux/Admin | 38.037 | 73.299 | 60.038 | 120.212 | 101.425 |
Recherche et développement | 24.049 | 45.785 | 47.743 | 63.4 | 48.712 |
Produits d'exploitation | -63.381 | -118.737 | -118.819 | -140.119 | -114.239 |
Produits (charges) d'intérêts, nets Hors exploitation | 15.614 | -66.793 | -9.915 | -9.199 | -11.418 |
Autres, nets | -1.483 | 6.89 | -13.884 | 0.575 | 1.801 |
Résultat net avant impôts | -49.25 | -178.64 | -142.618 | -148.743 | -123.856 |
Résultat net après impôts | -48.83 | -178.521 | -105.086 | -148.037 | -129.106 |
Résultat net avant éléments extra | -48.83 | -178.521 | -105.086 | -148.037 | -129.106 |
Résultat net | -38.157 | -247.412 | -192.528 | -148.037 | -129.106 |
Total Adjustments to Net Income | 0 | -0.268 | -80.79 | 0 | |
Revenu disponible pour les actionnaires ordinaires, hors éléments exceptionnels | -48.83 | -178.521 | -105.354 | -228.827 | -129.106 |
Bénéfice disponible pour les actionnaires ordinaires, y compris les éléments exceptionnels | -38.157 | -247.412 | -192.796 | -228.827 | -129.106 |
Résultat net dilué | -38.157 | -247.412 | -192.796 | -228.827 | -129.106 |
Moyenne pondérée des actions diluées | 7.63511 | 3.84619 | 1.10052 | 1.80655 | 1.80655 |
BPA dilué hors éléments extraordinaires | -6.39546 | -46.4151 | -95.7315 | -126.665 | -71.4654 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
BPA dilué normalisé | -6.21668 | -46.263 | -89.1165 | -126.665 | -71.4654 |
Charges (revenus) inhabituelles | 1.6 | 0.9 | 11.2 | ||
Total des éléments extraordinaires | 10.673 | -68.891 | -87.442 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Revenu total | 0.002 | 0.014 | 0.08 | 0.104 | 0.107 |
Revenu | 0.002 | 0.014 | 0.08 | 0.104 | 0.107 |
Coût des recettes, total | |||||
Résultat brut | |||||
Total des frais d'exploitation | 15.546 | 13.79 | 13.967 | 14.314 | 20.015 |
Total des frais de vente/Généraux/Admin | 8.356 | 8.023 | 8.147 | 8.41 | 13.457 |
Recherche et développement | 7.19 | 5.767 | 5.82 | 5.904 | 6.558 |
Produits d'exploitation | -15.544 | -13.776 | -13.887 | -14.21 | -19.908 |
Produits (charges) d'intérêts, nets Hors exploitation | -1.816 | 2.773 | -0.729 | 7.341 | 6.229 |
Autres, nets | -0.081 | -2.207 | -0.1 | 0.035 | -0.811 |
Résultat net avant impôts | -17.441 | -13.21 | -14.716 | -6.834 | -14.49 |
Résultat net après impôts | -17.441 | -13.469 | -14.874 | -5.997 | -14.49 |
Résultat net avant éléments extra | -17.441 | -13.469 | -14.874 | -5.997 | -14.49 |
Total des éléments extraordinaires | 0 | -0.253 | 9.76 | 0.484 | 0.682 |
Résultat net | -17.441 | -13.722 | -5.114 | -5.513 | -13.808 |
Total Adjustments to Net Income | |||||
Revenu disponible pour les actionnaires ordinaires, hors éléments exceptionnels | -17.441 | -13.469 | -14.874 | -5.997 | -14.49 |
Bénéfice disponible pour les actionnaires ordinaires, y compris les éléments exceptionnels | -17.441 | -13.722 | -5.114 | -5.513 | -13.808 |
Résultat net dilué | -17.441 | -13.722 | -5.114 | -5.513 | -13.808 |
Moyenne pondérée des actions diluées | 10.9706 | 8.3577 | 7.47815 | 7.37487 | 7.32807 |
BPA dilué hors éléments extraordinaires | -1.5898 | -1.61157 | -1.98899 | -0.81317 | -1.97733 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA dilué normalisé | -1.5898 | -1.61157 | -1.98899 | -0.81317 | -1.97733 |
- Annuel
- Trimestriel
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total de l'actif à court terme | 38.116 | 98.775 | 126.338 | 74.648 | 88.946 |
Espèces et placements à court terme | 30.486 | 88.397 | 92.076 | 33.042 | 69.205 |
Trésorerie et équivalents | 30.486 | 88.397 | 92.076 | 33.042 | 49.005 |
Investissements à court terme | 0 | 20.2 | |||
Total des créances, nettes | 0.828 | 0.653 | 6.634 | 22.823 | 8.146 |
Accounts Receivable - Trade, Net | 0 | 0.653 | 6.634 | 22.189 | 1.952 |
Total Inventory | 10.937 | 7.616 | |||
Prepaid Expenses | 3.634 | 6.123 | 8.521 | 6.476 | 3.375 |
Other Current Assets, Total | 3.168 | 3.602 | 19.107 | 1.37 | 0.604 |
Total Assets | 53.525 | 108.839 | 154.44 | 101.727 | 116.397 |
Property/Plant/Equipment, Total - Net | 3.136 | 3.666 | 8.106 | 15.891 | 15.339 |
Property/Plant/Equipment, Total - Gross | 7.135 | 9.287 | 13.894 | 33.201 | 29.455 |
Accumulated Depreciation, Total | -3.999 | -5.621 | -5.788 | -17.31 | -14.116 |
Goodwill, Net | 6.072 | 6.072 | 6.072 | 6.219 | 6.219 |
Intangibles, Net | 4.771 | 5.699 | |||
Other Long Term Assets, Total | 0.201 | 0.326 | 13.924 | 0.198 | 0.194 |
Total Current Liabilities | 23.305 | 61.609 | 72.67 | 100.337 | 78.057 |
Accounts Payable | 3.606 | 8.709 | 17.379 | 15.754 | 11.035 |
Accrued Expenses | 14.064 | 30.847 | 50.312 | 77.571 | 61.019 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0.012 | 0.338 | 0.968 | 1.229 |
Other Current Liabilities, Total | 5.635 | 22.041 | 4.641 | 6.044 | 4.774 |
Total Liabilities | 155.812 | 193.815 | 261.434 | 185.601 | 153.365 |
Total Long Term Debt | 127.811 | 126.392 | 160.203 | 72.405 | 71.508 |
Long Term Debt | 127.811 | 126.392 | 160.161 | 72.047 | 70.615 |
Capital Lease Obligations | 0.042 | 0.358 | 0.893 | ||
Other Liabilities, Total | 4.696 | 5.814 | 28.561 | 12.859 | 3.8 |
Total Equity | -102.287 | -84.976 | -106.994 | -83.874 | -36.968 |
Preferred Stock - Non Redeemable, Net | 0.106 | 0.02 | |||
Common Stock | 0.008 | 0.006 | 0.059 | 0.052 | 0.05 |
Additional Paid-In Capital | 743.626 | 722.782 | 452.992 | 283.217 | 124.202 |
Retained Earnings (Accumulated Deficit) | -826.843 | -788.686 | -541.274 | -348.478 | -142.469 |
Treasury Stock - Common | -19.078 | -19.078 | -18.771 | -18.771 | -18.771 |
Total Liabilities & Shareholders’ Equity | 53.525 | 108.839 | 154.44 | 101.727 | 116.397 |
Total Common Shares Outstanding | 8.9285 | 7.27489 | 2.23089 | 1.80655 | 1.80655 |
Long Term Investments | 6 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total de l'actif à court terme | 37.168 | 38.116 | 46.36 | 60.145 | 75.02 |
Espèces et placements à court terme | 30.463 | 30.486 | 37.06 | 48.506 | 67.234 |
Trésorerie et équivalents | 30.463 | 30.486 | 37.06 | 48.506 | 67.234 |
Total des créances, nettes | 0.828 | 0.828 | 0.828 | 0.817 | 0 |
Accounts Receivable - Trade, Net | 0 | 0 | 0 | 0 | |
Total Inventory | |||||
Prepaid Expenses | 3.059 | 3.634 | 5.461 | 7.615 | 4.492 |
Other Current Assets, Total | 2.818 | 3.168 | 3.011 | 3.207 | 3.294 |
Total Assets | 53.243 | 53.525 | 62.614 | 77.101 | 86.738 |
Property/Plant/Equipment, Total - Net | 3.744 | 3.136 | 3.955 | 4.657 | 5.32 |
Property/Plant/Equipment, Total - Gross | 6.036 | 7.135 | 7.944 | 9.803 | 10.756 |
Accumulated Depreciation, Total | -2.292 | -3.999 | -3.989 | -5.146 | -5.436 |
Goodwill, Net | 6.072 | 6.072 | 6.072 | 6.072 | 6.072 |
Intangibles, Net | |||||
Other Long Term Assets, Total | 0.259 | 0.201 | 0.227 | 0.227 | 0.326 |
Total Current Liabilities | 25.083 | 23.305 | 27.391 | 40.584 | 46.725 |
Accounts Payable | 3.422 | 3.606 | 2.356 | 4.315 | 5.38 |
Accrued Expenses | 16.333 | 14.064 | 19.543 | 28.803 | 28.993 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0 | 0 | 0 | |
Other Current Liabilities, Total | 5.328 | 5.635 | 5.492 | 7.466 | 12.352 |
Total Liabilities | 158.241 | 155.812 | 160.057 | 173.207 | 179.923 |
Total Long Term Debt | 128.185 | 127.811 | 127.445 | 127.086 | 126.736 |
Long Term Debt | 128.185 | 127.811 | 127.445 | 127.086 | 126.736 |
Capital Lease Obligations | |||||
Other Liabilities, Total | 4.973 | 4.696 | 5.221 | 5.537 | 6.462 |
Total Equity | -104.998 | -102.287 | -97.443 | -96.106 | -93.185 |
Common Stock | 0.011 | 0.008 | 0.153 | 0.15 | 0.148 |
Additional Paid-In Capital | 758.353 | 743.626 | 734.607 | 730.833 | 728.243 |
Retained Earnings (Accumulated Deficit) | -844.284 | -826.843 | -813.121 | -808.007 | -802.494 |
Treasury Stock - Common | -19.078 | -19.078 | -19.082 | -19.082 | -19.082 |
Total Liabilities & Shareholders’ Equity | 53.243 | 53.525 | 62.614 | 77.101 | 86.738 |
Total Common Shares Outstanding | 11.859 | 8.9285 | 7.56389 | 7.4516 | 7.36792 |
Long Term Investments | 6 | 6 | 6 | 6 |
- Annuel
- Trimestriel
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Revenu net/Ligne de départ | -38.157 | -247.412 | -192.528 | -148.037 | -129.106 |
Liquidités provenant des activités d'exploitation | -64.417 | -167.486 | -165.744 | -106.124 | -65.126 |
Liquidités provenant des activités d'exploitation | 0.907 | 1.437 | 5.059 | 6.349 | 6.073 |
Deferred Taxes | 0 | 6.245 | |||
Éléments non monétaires | -22.517 | 104.353 | 72.895 | 2.91 | 5.501 |
Cash Taxes Paid | 0.031 | 0.367 | 0.062 | 0.006 | 0.211 |
Intérêts payés en espèces | 5.871 | 7.536 | 3.927 | 7.529 | 7.618 |
Variation du fonds de roulement | -4.65 | -25.864 | -51.17 | 32.654 | 46.161 |
Flux de trésorerie liés aux activités d'investissement | -0.792 | -1.242 | -4.944 | 16.525 | 55.831 |
Dépenses d'investissement | -0.792 | -0.855 | -4.944 | -3.725 | -4.832 |
Autres éléments de flux de trésorerie d'investissement, total | 0 | -0.387 | 0 | 20.25 | 60.663 |
Flux de trésorerie provenant des activités de financement | 7.298 | 165.049 | 229.722 | 73.636 | -12.807 |
Éléments de flux de trésorerie de financement | -5.12 | -5.532 | -6.745 | -4.679 | -0.25 |
Émission (remboursement) d'actions, nette | 12.43 | 172.224 | 137.742 | 79.59 | -10.807 |
Émission (remboursement) de la dette, nette | -0.012 | -1.643 | 98.725 | -1.275 | -1.75 |
Variation nette de la trésorerie | -57.911 | -3.679 | 59.034 | -15.963 | -22.102 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -17.441 | -38.157 | -24.435 | -19.321 | -13.808 |
Cash From Operating Activities | -12.098 | -64.417 | -53.399 | -43.594 | -23.955 |
Cash From Operating Activities | 0.147 | 0.907 | 0.749 | 0.547 | 0.322 |
Non-Cash Items | 2.003 | -22.517 | -22.436 | -13.221 | -5.045 |
Cash Taxes Paid | 0 | 0.031 | 0.018 | 0.017 | 0.001 |
Cash Interest Paid | 5.871 | 4.811 | 4.811 | 0 | |
Changes in Working Capital | 3.193 | -4.65 | -7.277 | -11.599 | -5.424 |
Cash From Investing Activities | -0.006 | -0.792 | -0.72 | -0.556 | -0.342 |
Capital Expenditures | -0.016 | -0.792 | -0.72 | -0.556 | -0.342 |
Cash From Financing Activities | 12.081 | 7.298 | 2.782 | 4.259 | 3.134 |
Financing Cash Flow Items | -0.802 | -5.12 | -3.748 | -0.612 | -0.48 |
Issuance (Retirement) of Stock, Net | 12.883 | 12.43 | 6.542 | 4.883 | 3.626 |
Issuance (Retirement) of Debt, Net | 0 | -0.012 | -0.012 | -0.012 | -0.012 |
Net Change in Cash | -0.023 | -57.911 | -51.337 | -39.891 | -21.163 |
Other Investing Cash Flow Items, Total | 0.01 | 0 | 0 | 0 | 0 |
Nom de l'investisseur | Catégorie de l'investisseur | Pourcentage de l'encours | Actions détenues | Changement d'actions | Date d'avoirs | Taux du chiffre d'affaires |
---|---|---|---|---|---|---|
Athyrium Capital Management, LP | Investment Advisor/Hedge Fund | 14.2885 | 1694481 | -1150962 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.029 | 240617 | 4604 | 2023-03-31 | LOW |
Mohanty (Aditya P) | Individual Investor | 1.8461 | 218929 | -11249 | 2023-05-15 | HIGH |
Heights Capital Management, Inc. | Investment Advisor | 1.2649 | 150000 | -170000 | 2021-12-31 | LOW |
d'Esparbes (Eric) | Individual Investor | 0.823 | 97599 | -2807 | 2023-05-15 | HIGH |
Neumann (Clarke William) | Individual Investor | 0.7599 | 90118 | -2368 | 2023-05-15 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.5485 | 65051 | -3 | 2023-03-31 | LOW |
GSA Capital Partners LLP | Hedge Fund | 0.4849 | 57501 | -26079 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.3718 | 44092 | -3 | 2023-03-31 | LOW |
Schonfeld Strategic Advisors LLC | Hedge Fund | 0.3584 | 42500 | 42500 | 2023-03-31 | HIGH |
Creative Planning, Inc. | Investment Advisor/Hedge Fund | 0.1771 | 21000 | 21000 | 2023-03-31 | LOW |
LPL Financial LLC | Investment Advisor | 0.1747 | 20718 | 19799 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1482 | 17573 | -1 | 2023-03-31 | LOW |
Bridgeway Capital Management, LLC | Investment Advisor | 0.1457 | 17280 | 0 | 2023-03-31 | LOW |
Cantor Fitzgerald, L.P | Investment Advisor | 0.1383 | 16400 | 16400 | 2023-03-31 | HIGH |
CIBC Asset Management Inc. | Investment Advisor | 0.1274 | 15110 | 15110 | 2023-03-31 | LOW |
Group One Trading, L.P. | Research Firm | 0.1107 | 13132 | 11697 | 2023-03-31 | HIGH |
Millennium Management LLC | Hedge Fund | 0.1059 | 12563 | -61622 | 2023-03-31 | HIGH |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.0953 | 11306 | 2620 | 2023-03-31 | LOW |
Susquehanna International Group, LLP | Investment Advisor | 0.0913 | 10833 | 2300 | 2023-03-31 | MED |
Pourquoi choisir capital.com? Nos chiffres parlent d'eux-mêmes.
Capital.com Group535K+
Tradeurs
87K+
Clients actifs par mois
$113M+
Volume d'investissement par mois
$64M+
Retrait par mois
Trading calculator
Calculez votre P&L hypothétique si vous aviez ouvert une transaction CFD à une certaine date (sélectionnez une date) et l'aviez fermée à une autre date (sélectionnez une date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Industry: | Bio Therapeutic Drugs |
4330 La Jolla Village Drive
Suite 200
SAN DIEGO
CALIFORNIA 92122
US
Compte de résultat
- Annual
- Quarterly
Les gens regardent aussi
Êtes-vous toujours à la recherche d'un broker de confiance?
Rejoignez les plus de 535 000 traders du monde entier qui ont choisi de trader avec Capital.com